Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Premier price target raised to $36 from $34 at Barclays » 05:53
11/18/21
11/18
05:53
11/18/21
05:53
PINC

Premier

$41.24 /

+1.08 (+2.69%)

Barclays analyst Steve…

Barclays analyst Steve Valiquette raised the firm's price target on Premier to $36 from $34 and keeps an Underweight rating on the shares. At its investor day, Premier discussed its business diversification growth strategy and gave color on revenue targets, Valiquette tells investors in a research note.

ShowHide Related Items >><<
PINC Premier
$41.24 /

+1.08 (+2.69%)

PINC Premier
$41.24 /

+1.08 (+2.69%)

11/03/21 Piper Sandler
Premier price target raised to $39 from $31 at Piper Sandler
05/28/21
Fly Intel: Top five analyst downgrades
05/28/21 Barclays
Barclays double downgrades Premier with multiple expansion less likely
05/28/21 Barclays
Premier downgraded to Underweight from Overweight at Barclays
PINC Premier
$41.24 /

+1.08 (+2.69%)

PINC Premier
$41.24 /

+1.08 (+2.69%)

Recommendations
Premier price target raised to $39 from $31 at Piper Sandler » 08:55
11/03/21
11/03
08:55
11/03/21
08:55
PINC

Premier

$39.63 /

+0.155 (+0.39%)

Piper Sandler analyst…

Piper Sandler analyst Sean Wieland raised the firm's price target on Premier to $39 from $31 and keeps a Neutral rating on the shares following the fiscal Q1 beat.

ShowHide Related Items >><<
PINC Premier
$39.63 /

+0.155 (+0.39%)

PINC Premier
$39.63 /

+0.155 (+0.39%)

05/28/21
Fly Intel: Top five analyst downgrades
05/28/21 Barclays
Barclays double downgrades Premier with multiple expansion less likely
05/28/21 Barclays
Premier downgraded to Underweight from Overweight at Barclays
05/04/21 Piper Sandler
Premier price target lowered to $31 from $36 at Piper Sandler
PINC Premier
$39.63 /

+0.155 (+0.39%)

PINC Premier
$39.63 /

+0.155 (+0.39%)

Earnings
Premier raises FY22 adjusted EPS view to $2.56-$2.66 from $2.50-$2.60 » 07:11
11/02/21
11/02
07:11
11/02/21
07:11
PINC

Premier

$39.47 /

+0.54 (+1.39%)

FY22 consensu $2.54.…

FY22 consensu $2.54. Backs FY22 revenue view $1.32B-$1.43B, consensus $1.39B

ShowHide Related Items >><<
PINC Premier
$39.47 /

+0.54 (+1.39%)

PINC Premier
$39.47 /

+0.54 (+1.39%)

05/28/21
Fly Intel: Top five analyst downgrades
05/28/21 Barclays
Barclays double downgrades Premier with multiple expansion less likely
05/28/21 Barclays
Premier downgraded to Underweight from Overweight at Barclays
05/04/21 Piper Sandler
Premier price target lowered to $31 from $36 at Piper Sandler
PINC Premier
$39.47 /

+0.54 (+1.39%)

PINC Premier
$39.47 /

+0.54 (+1.39%)

Earnings
Premier reports Q1 adjusted EPS 64c, consensus 59c » 07:09
11/02/21
11/02
07:09
11/02/21
07:09
PINC

Premier

$39.47 /

+0.54 (+1.39%)

Reports Q1 revenue…

Reports Q1 revenue $365.1M, consensus $348.35M.

ShowHide Related Items >><<
PINC Premier
$39.47 /

+0.54 (+1.39%)

PINC Premier
$39.47 /

+0.54 (+1.39%)

05/28/21
Fly Intel: Top five analyst downgrades
05/28/21 Barclays
Barclays double downgrades Premier with multiple expansion less likely
05/28/21 Barclays
Premier downgraded to Underweight from Overweight at Barclays
05/04/21 Piper Sandler
Premier price target lowered to $31 from $36 at Piper Sandler
PINC Premier
$39.47 /

+0.54 (+1.39%)

PINC Premier
$39.47 /

+0.54 (+1.39%)

Hot Stocks
Premier, Resilinc announce supply chain transparency collaboration » 08:33
10/26/21
10/26
08:33
10/26/21
08:33
PINC

Premier

$39.11 /

-0.825 (-2.07%)

Premier and Resilinc…

Premier and Resilinc announced a new collaboration to drive greater supply chain transparency, risk mitigation and business continuity for U.S. healthcare providers. The Resilinc and Premier initiative expands Premier's supply chain mapping footprint to encompass more than 1,300 suppliers and 15,000 sites.

ShowHide Related Items >><<
PINC Premier
$39.11 /

-0.825 (-2.07%)

PINC Premier
$39.11 /

-0.825 (-2.07%)

05/28/21
Fly Intel: Top five analyst downgrades
05/28/21 Barclays
Barclays double downgrades Premier with multiple expansion less likely
05/28/21 Barclays
Premier downgraded to Underweight from Overweight at Barclays
05/04/21 Piper Sandler
Premier price target lowered to $31 from $36 at Piper Sandler
PINC Premier
$39.11 /

-0.825 (-2.07%)

PINC Premier
$39.11 /

-0.825 (-2.07%)

Over a quarter ago
Hot Stocks
Assure Holdings secures agreement with Premier » 08:57
09/08/21
09/08
08:57
09/08/21
08:57
ARHH

Assure Holdings

$1.53 /

-0.07 (-4.38%)

, PINC

Premier

$37.35 /

+0.42 (+1.14%)

Assure Holdings (ARHH) is…

Assure Holdings (ARHH) is pleased to announce that it has received a systemwide contract with Premier (PINC). Effective November 1, 2021, the contract will enable Premier members, at their discretion, to take advantage of pricing and terms pre-negotiated by Premier for Assure's Joint Commission accredited IONM services. Premier is a leading healthcare improvement company, uniting an alliance of approximately 4,400 U.S. hospitals and 225,000 other providers to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, consulting and other services, Premier enables better care and outcomes at a lower cost.

ShowHide Related Items >><<
PINC Premier
$37.35 /

+0.42 (+1.14%)

ARHH Assure Holdings
$1.53 /

-0.07 (-4.38%)

ARHH Assure Holdings
$1.53 /

-0.07 (-4.38%)

PINC Premier
$37.35 /

+0.42 (+1.14%)

05/28/21
Fly Intel: Top five analyst downgrades
05/28/21 Barclays
Barclays double downgrades Premier with multiple expansion less likely
05/28/21 Barclays
Premier downgraded to Underweight from Overweight at Barclays
05/04/21 Piper Sandler
Premier price target lowered to $31 from $36 at Piper Sandler
PINC Premier
$37.35 /

+0.42 (+1.14%)

ARHH Assure Holdings
$1.53 /

-0.07 (-4.38%)

PINC Premier
$37.35 /

+0.42 (+1.14%)

Hot Stocks
Premier and 11 leading health systems invest in Exela for supply/manufacturing » 07:47
09/08/21
09/08
07:47
09/08/21
07:47
PINC

Premier

$37.35 /

+0.42 (+1.14%)

Premier and 11 leading…

Premier and 11 leading health systems acquired a minority stake in Exela Holdings the holding company of Exela Pharma Sciences to secure vital supply of pharmaceutical products and support domestic production. Under the arrangement, participating Premier member health systems are expected to have uninterrupted supply of 19 pharmaceutical products, including several generic injectables that frequently appear on the U.S. Food and Drug Administration's drug shortage list, as well as 503B pharmaceutical products made by Exela. Exela primarily sources active pharmaceutical ingredients from the United States and Europe, and manufactures finished-dose products in its recently expanded state-of-the-art U.S. manufacturing facility in Lenoir, NC. Exela's manufacturing capacity provides participating Premier members with a unique opportunity to bolster the supply of critical products and support domestic manufacturing infrastructure. Pervasive drug shortages for more than a decade have led to sub-optimal patient outcomes and approximately $230M in additional annual drug costs. COVID-19 has exacerbated pharmaceutical sourcing challenges as overseas manufacturing, export bans from large producers of APIs and demand spikes have, at times, left providers struggling to secure basic, life-saving therapies for patients.

ShowHide Related Items >><<
PINC Premier
$37.35 /

+0.42 (+1.14%)

PINC Premier
$37.35 /

+0.42 (+1.14%)

05/28/21
Fly Intel: Top five analyst downgrades
05/28/21 Barclays
Barclays double downgrades Premier with multiple expansion less likely
05/28/21 Barclays
Premier downgraded to Underweight from Overweight at Barclays
05/04/21 Piper Sandler
Premier price target lowered to $31 from $36 at Piper Sandler
PINC Premier
$37.35 /

+0.42 (+1.14%)

PINC Premier
$37.35 /

+0.42 (+1.14%)

Hot Stocks
Premier decreases size of board, enhances corporate governance profile » 07:42
09/07/21
09/07
07:42
09/07/21
07:42
PINC

Premier

$36.93 /

-0.13 (-0.35%)

Premier announced it has…

Premier announced it has decreased the size of its Board of Directors from 15 to 11, effective August 31, to further enhance the company's governance profile. In connection with the decrease in the size of the Board, five directors agreed to resign, also effective August 31. Following these changes, 90% of Premier's Board is independent and 40% is female or racially diverse, with an average director tenure of approximately five years. Reflecting the Board's commitment to diversity, the company expects to add an additional female or other diverse director with the relevant competencies and experience that support the company's strategic plan. Terry Shaw, Chairman of Premier's Board, said, "Over the past year, we have made important changes at Premier to simplify the company's corporate structure, align our governance policies with best practices, and enhance the Board's ability to effectively oversee the business and drive value creation. Today's announcement is a continuation of these efforts and reflects feedback we have received through our ongoing engagement efforts with stockholders. We are committed to maintaining a strong Board with a balanced mix of voices, fostering a robust dialogue for the benefit of our stockholders, members, customers and employees - as well as the patients, communities and healthcare systems we ultimately serve." Premier's continuing Board members include John Bigalke, Helen Boudreau, Jody Davids, Peter Fine, Marc Miller, Marvin O'Quinn, Terry Shaw, Richard Statuto and Ellen Wolf, along with Michael Alkire, Premier's president and CEO and the company's only non-independent director. Directors who have voluntarily resigned include Barclay Berdan, Stephen D'Arcy, David Langstaff, William Mayer and Scott Reiner. Premier noted that the voluntary resignations are not due to any disagreement with the Board or company management.

ShowHide Related Items >><<
PINC Premier
$36.93 /

-0.13 (-0.35%)

PINC Premier
$36.93 /

-0.13 (-0.35%)

05/28/21
Fly Intel: Top five analyst downgrades
05/28/21 Barclays
Barclays double downgrades Premier with multiple expansion less likely
05/28/21 Barclays
Premier downgraded to Underweight from Overweight at Barclays
05/04/21 Piper Sandler
Premier price target lowered to $31 from $36 at Piper Sandler
PINC Premier
$36.93 /

-0.13 (-0.35%)

PINC Premier
$36.93 /

-0.13 (-0.35%)

Earnings
Premier sees FY22 adjusted EPS $2.50-$2.60, consensus $2.43 » 06:36
08/17/21
08/17
06:36
08/17/21
06:36
PINC

Premier

$35.97 /

-0.12 (-0.33%)

Sees FY22 revenue…

Sees FY22 revenue $1.32B-$1.43B, consensus $1.46B. Sees FY22 adjusted EBITDA $483M-$500M. The company also reiterated that, adjusted for the impact of the COVID-19 pandemic, beginning in fiscal year 2022, it expects to target a multi-year, compound annual growth rate in the mid-to-high single digits for consolidated net revenue, adjusted EBITDA and adjusted EPS. FY22 guidance assumes the realization of the following key assumptions: net administrative fees revenue of $570M-$590M; direct sourcing products revenue of $350M-$390M; net revenue available under contract that represents approximately 86%-93% of the FY22 guidance range; capital expenditures of $100M-$110M; effective tax rate of 23%, ETR increased from 22% in FY21; free cash flow approximating 35%-50% of adjusted EBITDA; per-share guidance does not include the impact of share repurchases under the previously authorized $250M stock repurchase plan; the timing and amount of any share repurchases will be determined by management based on market conditions, share price and other factors: does not include the effect of any potential future significant acquisitions.

ShowHide Related Items >><<
PINC Premier
$35.97 /

-0.12 (-0.33%)

PINC Premier
$35.97 /

-0.12 (-0.33%)

05/28/21
Fly Intel: Top five analyst downgrades
05/28/21 Barclays
Barclays double downgrades Premier with multiple expansion less likely
05/28/21 Barclays
Premier downgraded to Underweight from Overweight at Barclays
05/04/21 Piper Sandler
Premier price target lowered to $31 from $36 at Piper Sandler
PINC Premier
$35.97 /

-0.12 (-0.33%)

PINC Premier
$35.97 /

-0.12 (-0.33%)

Earnings
Premier reports Q4 adjusted EPS 60c, consensus 59c » 06:33
08/17/21
08/17
06:33
08/17/21
06:33
PINC

Premier

$35.97 /

-0.12 (-0.33%)

Reports Q4 revenue…

Reports Q4 revenue $481.5M, consensus $447.82M. "We are pleased with our Q4 performance which reflects another quarter of solid execution," said Michael J. Alkire, Premier's president and CEO. "In addition, I am so proud of our employees who continue to work tirelessly to support each other, our members and other customers in a challenging and dynamic environment. We are committed to providing innovative, technology-based solutions to help drive better healthcare quality, lower costs and a more resilient supply chain."

ShowHide Related Items >><<
PINC Premier
$35.97 /

-0.12 (-0.33%)

PINC Premier
$35.97 /

-0.12 (-0.33%)

05/28/21
Fly Intel: Top five analyst downgrades
05/28/21 Barclays
Barclays double downgrades Premier with multiple expansion less likely
05/28/21 Barclays
Premier downgraded to Underweight from Overweight at Barclays
05/04/21 Piper Sandler
Premier price target lowered to $31 from $36 at Piper Sandler
PINC Premier
$35.97 /

-0.12 (-0.33%)

PINC Premier
$35.97 /

-0.12 (-0.33%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.